CONSOLIDATED INCOME STATEMENTS ¥ in Millions, shares in Millions, $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2026
CNY (¥)
¥ / shares
shares
|
Mar. 31, 2026
USD ($)
$ / shares
shares
|
Mar. 31, 2025
CNY (¥)
¥ / shares
shares
|
Mar. 31, 2024
CNY (¥)
¥ / shares
shares
|
|
| Income Statement [Abstract] | ||||
| Revenue | ¥ 1,023,670 | $ 148,401 | ¥ 996,347 | ¥ 941,168 |
| Cost of revenue | (616,136) | (89,321) | (598,285) | (586,323) |
| Product development expenses | (66,533) | (9,645) | (57,151) | (52,256) |
| Sales and marketing expenses | (245,023) | (35,521) | (144,021) | (115,141) |
| General and administrative expenses | (33,082) | (4,796) | (44,239) | (41,985) |
| Amortization and impairment of intangible assets | (5,079) | (736) | (6,336) | (21,592) |
| Impairment of goodwill | (9,515) | (1,380) | (6,171) | (10,521) |
| Other gains, net | 1,848 | 268 | 761 | 0 |
| Income from operations | 50,150 | 7,270 | 140,905 | 113,350 |
| Interest and investment income, net | 87,512 | 12,687 | 20,759 | (9,964) |
| Interest expense | (9,793) | (1,420) | (9,596) | (7,947) |
| Other income, net | 1,518 | 220 | 3,387 | 6,157 |
| Income before income tax and share of results of equity method investees | 129,387 | 18,757 | 155,455 | 101,596 |
| Income tax expenses | (30,045) | (4,356) | (35,445) | (22,529) |
| Share of results of equity method investees | 2,785 | 404 | 5,966 | (7,735) |
| Net income | 102,127 | 14,805 | 125,976 | 71,332 |
| Net loss attributable to noncontrolling interests | 1,465 | 213 | 4,133 | 8,677 |
| Net income attributable to Alibaba Group Holding Limited | 103,592 | 15,018 | 130,109 | 80,009 |
| (Accretion) Reversal of accretion of mezzanine equity | 2,312 | 335 | (639) | (268) |
| Net income attributable to ordinary shareholders | ¥ 105,904 | $ 15,353 | ¥ 129,470 | ¥ 79,741 |
| Earnings per share attributable to ordinary shareholders | ||||
| Basic | (per share) | ¥ 5.7 | $ 0.83 | ¥ 6.89 | ¥ 3.95 |
| Diluted | (per share) | 5.5 | 0.8 | 6.7 | 3.91 |
| Earnings per ADS attributable to ordinary shareholders (one ADS equals eight ordinary shares) | ||||
| Basic | (per share) | 45.63 | 6.61 | 55.12 | 31.61 |
| Diluted | (per share) | ¥ 44 | $ 6.38 | ¥ 53.59 | ¥ 31.24 |
| Weighted average number of shares used in computing earnings per share (million shares) | ||||
| Basic | 18,568 | 18,568 | 18,791 | 20,182 |
| Diluted | 19,235 | 19,235 | 19,318 | 20,359 |
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of intangible assets to fair value. No definition available.
|
| X | ||||||||||
- Definition n/a No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each ADS outstanding during the reporting period. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each ADS outstanding during the reporting period and to each ADS that would have been outstanding assuming the issuance of ADS for all dilutive potential ADS outstanding during the reporting period. No definition available.
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the after tax net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. No definition available.
|
| X | ||||||||||
- Definition This element represents: 1) the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination; 2) net gain (loss) recognized by the entity as a result of deconsolidation/disposal of subsidiaries/investments; 3) impairment loss on investments and 4) dividends, interest on securities and net gains or losses on securities. No definition available.
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|